"First-In-Man" Clinical trial: HOCM (Hypertrophic Cardiomyopathy) on Apr. 2021
Tau-PNU Medical Inc.
We are pleased to announce that our first HOCM (Hypertrophic Obstructive Cardiomyopathy) patient was treated with Tau PNU Medical's TIRA device (Cooled RF Ablation Catheter) at Pusan National University Medical Center on 21st April 2021. This monumental milestone for Tau-PNU Medical is a product of 30 months of intensive R&D and pre-clinical trial efforts from all of our team members of Tau-PNU Medical. This set of early feasibility trials will be performed across accredited medical centers in South Korea.
link http://www.tau-pnu.com/newsroom_view.php?no=28&schYear=&schTxt=
| 이전글 | TCT 2021 Conference (Nov. 4-6) | 2021-05-10 |
| 다음글 | ㈜알에프메디컬, ㈜타우피엔유메디칼과 공동개발 협약 체결 | 2021-04-20 |
TOP
Tau-Medical Inc.
Tel +82.51.515.8783
Fax +82.51.367.8784
E-mail tau@tau-pnu.co.kr 
© Tau-Medical Inc. All Rights Reserved.